Full-Time

Director – CRM & Customer Lifecycle Marketing

Curaleaf

Curaleaf

1,001-5,000 employees

Cannabis cultivation, processing, and retailing

Compensation Overview

$156k - $173k/yr

No H1B Sponsorship

Stamford, CT, USA

In Person

Bachelor's

Category
Growth & Marketing (1)
Required Skills
Data Analysis

Get referred to Curaleaf

See people who can refer or advise you

Requirements
  • 8 to 12+ years of experience in CRM, lifecycle marketing, retention marketing, customer strategy, loyalty, database marketing, or related fields
  • Experience using customer data to build segmentation strategies and personalized marketing programs
  • Strong analytical skills, with the ability to translate data into clear insights, actions, and business recommendations
  • Experience building customer lifecycle programs across email, SMS, loyalty, digital, e-commerce, or retail channels
  • Strong understanding of CRM platforms, marketing automation, customer data, campaign operations, testing, and measurement
  • Experience partnering with Analytics, Technology, Digital, Retail, Creative, and Brandteams
  • Proven ability to build structure, process, and roadmaps in a fast-moving or evolving business environment
  • Strong communication and presentation skills, including the ability to influence senior leaders and cross-functional partners
  • Strong project management skills, with the ability to manage multiple priorities and drive work forward with urgency
  • Bachelor’s degree
Responsibilities
  • Build and Lead the CRM Strategy: Assess Curaleaf’s current CRM approach, data assets, tools, capabilities, processes, and performance
  • Define a clear CRM vision, roadmap, and operating model focused primarily on retail growth
  • Establish a more disciplined approach to lifecycle marketing, customer segmentation, personalization, testing, and measurement
  • Build CRM strategies that support key business objectives, including new customer acquisition, repeat purchase, retention, reactivation, frequency, basket growth, and customer lifetime value
  • Create a practical roadmap that balances immediate business impact with longer-term capability building
  • Turn Customer Data into Actionable Segments: Analyze Curaleaf’s customer database to identify meaningful behavioral, value-based, geographic, category, frequency, and lifecycle segments
  • Develop actionable customer segments, such as new customers, high-value customers, category loyalists, promotion-sensitive shoppers, recently lapsed customers, long-term lapsed customers, and cross-sell opportunities
  • Partner with Analytics and Retail teams to understand customer behavior by market, store, category, brand, product type, and purchase occasion
  • Translate data into clear insights and recommendations that can be used by Marketing, Retail, Brand, Digital, and Merchandising teams
  • Build a segmentation framework that helps Curaleaf move from broad promotional blasts to more targeted, personalized, and effective customer engagement
  • Drive Retail Lifecycle Marketing: Design and optimize lifecycle programs across the customer journey, including onboarding, first-to-second purchase, category education, repeat purchase, loyalty, lapsed customer reactivation, and win-back
  • Develop CRM programs that help customers navigate the cannabis category, understand product formats, discover brands, and find products that fit their needs
  • Create targeted campaigns that support retail priorities, including traffic-driving offers, market-specific needs, product launches, seasonal events, and key promotional moments
  • Partner with Retail and Trade Marketing to ensure CRM supports store-level and market-level objectives
  • Build CRM programs that help Curaleaf grow both existing customer value and new customer conversion
  • Build a Test-and-Learn Culture: Establish a disciplined testing roadmap across audience segments, offers, messaging, timing, cadence, channels, and creative
  • Use data to determine what is working, what is not, and where Curaleaf should scale, optimize, or stop activity
  • Partner with Creative and Brand teams to ensure CRM messaging is not only targeted, but also on-brand, engaging, and easy for customers to understand
  • Develop clear reporting that connects CRM activity to business outcomes, including traffic, revenue, repeat rate, retention, basket size, category growth, offer performance, and customer lifetime value
  • Help the organization move from activity-based CRM to performance-based CRM
  • Partner Cross-Functionally Across the Business: Work closely with Retail Sales and Retail Operations to understand business priorities, store-level needs, customer behavior, and market dynamics
  • Partner with Brand Marketing to ensure CRM supports Curaleaf’s brand portfolio, including Select, Grassroots, Find, Jams, Anthem, Dark Heart, and other priority brands
  • Collaborate with Digital and E-Commerce teams to connect CRM with website, menu, product content, online ordering, and customer data capture
  • Influence cross-functional partners through strong insights, clear storytelling, and a practical understanding of what will drive the business
  • Who You Are section is not included as a separate item here
Desired Qualifications
  • Experience in retail, Consumer Packaged Goods, multi-unit retail, cannabis, beverage alcohol, wellness, or another regulated consumer category
  • Experience with loyalty programs, first-party data strategy, customer data platforms, or customer identity resolution
  • Experience working across multiple markets with different regulatory, operational, or commercial requirements
  • Experience with CRM platforms such as Salesforce Marketing Cloud, Braze, Klaviyo, Adobe Campaign, HubSpot, or similar tools
  • Experience building customer dashboards, performance scorecards, or test-and-learn measurement frameworks
  • Familiarity with cannabis consumers, dispensary retail, product formats, and state-by-state cannabis regulations is a plus

Curaleaf is a cannabis company that grows, processes, and sells cannabis products for medical and recreational use. It offers items such as tinctures, flowers, and edibles, and uses encapsulation technology to improve product absorption and effectiveness. Customers can buy at dispensaries or online, and the company also provides medical consultations and guidance services. Differentiators include its vertically integrated model (cultivation, processing, and retail) and its social responsibility efforts, such as the B NOBLE program that supports individuals with cannabis-related non-violent charges. The company’s goal is to provide reliable cannabis products and related services to a wide range of customers while advancing responsible access and advocacy through programs like B NOBLE.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wakefield, Massachusetts

Founded

2010

Get referred to Curaleaf

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $340.1 million, up 10%, with $12.5 million net income.
  • April 2026 authorized an $83 million buyback, supporting per-share results into 2027.
  • August 11, 2026 Aurora bid targets EU medical synergies and about $40 million savings.

What critics are saying

  • June 30, 2026 debt was $611.5 million against $107 million cash, squeezing optionality.
  • Aurora’s board can reject Curaleaf’s $4 bid, wasting management attention through late 2026.
  • New Jersey appealed Curaleaf’s labor-peace win, while May 2026 health-claims class actions persist.

What makes Curaleaf unique

  • July 2026 Spain registrations made Curaleaf first standardised medical cannabis supplier there.
  • Four 20 Pharma gives Curaleaf EU-GMP distribution across Germany and select European markets.
  • Florida scale matters: Curaleaf opened its 75th Florida dispensary on August 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Parental Leave

401(k) Retirement Plan

Life Insurance

Disability Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 18th, 2026
Curaleaf launches $4 hostile bid for Aurora Cannabis to access EU medical market

Curaleaf has formally launched its hostile takeover bid for Aurora Cannabis, offering $4 per share directly to shareholders. The offer represents a 45% premium on Aurora's 30-day average share price from 10 August, before Curaleaf announced its intentions. The proposed deal would create a combined company with a $3 billion market cap. Curaleaf projects approximately $40 million in annual cost synergies from the merger. The acquisition aims to give Curaleaf access to EU medical cannabis export markets, particularly Germany. Aurora possesses EU-GMP cultivation capacity that meets strict German import standards. Federal restrictions make direct cannabis exports challenging for US firms like Curaleaf. Curaleaf CEO Boris Jordan said initial friendly discussions with Aurora CEO Miguel Martin earlier this summer stalled, prompting the direct shareholder approach. Aurora's board has formed a special committee to review the offer.

PR Newswire
Aug 5th, 2026
Curaleaf reports $340M Q2 revenue with 10% growth and $12M net income

Curaleaf Holdings reported second quarter 2026 revenue of $340 million, representing 10% year-over-year growth driven by domestic and international segments that grew 7% and 26%, respectively. International revenue reached $51 million. The cannabis company posted net income of $12 million and adjusted EBITDA of $70 million, reflecting a 21% margin. Gross profit margin stood at 50%. Chairman and CEO Boris Jordan said the results demonstrate the company's "Built for Growth" strategy is gaining traction. He noted this marks the second consecutive quarter of domestic year-over-year growth. Curaleaf ended the quarter with $107 million in cash and $611.5 million in outstanding debt. The company invested $32.9 million in capital expenditures during the six-month period, focused on facility upgrades and automation.

PR Newswire
Jul 29th, 2026
Curaleaf opens 75th Florida dispensary, expanding US footprint to 167 locations

Curaleaf Holdings has opened its 75th dispensary in Florida, located in Boynton Beach. The cannabis retailer now operates 167 locations nationwide, with Florida representing nearly half of its retail footprint. The new store at 3575 W. Boynton Beach Boulevard is the company's sixth Florida opening this year. It offers medical cannabis products including Anthem pre-rolls, Dark Heart ultra-premium flower, and Select vaping products. Boris Jordan, chairman and CEO, said the opening reinforces Curaleaf's commitment to expanding access to cannabis products across Florida. A grand opening celebration is scheduled for 31 July and 1 August, featuring special promotions and giveaways. The dispensary operates 9:00 to 20:30 Monday through Saturday, and 10:00 to 18:00 on Sunday.

Yahoo Finance
Jul 13th, 2026
Curaleaf becomes first company to register standardised cannabis preparations in Spain

Curaleaf Holdings has become the first company to secure registration for standardised cannabis preparations in Spain under the country's new regulatory framework, Royal Decree 903/2025. Spain's medicines agency AEMPS approved two preparations — THC-dominant and CBD-dominant — developed by Curaleaf's Spanish manufacturing subsidiary. The registrations enable supply to hospital pharmacies, where the preparations can be used in magistral formulas under medical prescription. Royal Decree 903/2025, approved in October 2025, establishes Spain's regulatory framework for medicinal cannabis, setting production and quality standards. Curaleaf operates an EU-GMP certified manufacturing facility and R&D laboratory in Alicante. The company secured Spain's first licence to process medicinal cannabis derivatives for commercial distribution in May 2020. The preparations are expected to become available to patients through hospital pharmacies as Spain's regulated system develops.

PR Newswire
May 8th, 2026
Curaleaf opens two new Florida medical dispensaries, expanding state footprint to 73 locations

Curaleaf Holdings has opened two new medical cannabis dispensaries in Florida, located in Jacksonville Beach and Fernandina Beach. The openings bring the company's Florida dispensary count to 73 and its nationwide total to 165 locations. The Jacksonville Beach location sits on Beach Boulevard along US Route 90, whilst the Fernandina Beach dispensary is positioned on South 8th Street along Florida State Road 200. Both stores offer Curaleaf's Florida-exclusive products, including Reef flower, Grassroots flower and Select Briq 2. Chairman and CEO Boris Jordan said the expansion reflects the company's strategy to strengthen its presence in Florida's medical cannabis market. Grand opening celebrations will take place at both locations in May, featuring live entertainment, promotions and giveaways.